AlJohani, N. I. (2020) “Remission frequency versus remission quality in transplant-eligible older patients. Comment on: ‘Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301453.